Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter
This study has been terminated.
( Incomplete information )
Study NCT00421421   Information provided by GlaxoSmithKline

First Received on January 11, 2007.   Last Updated on November 26, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Benign Prostatic Hyperplasia
Additional conditions recognized in this trial
Hyperplasia
Prostatic Hyperplasia
Urinary Retention
More general conditions related to this trial
Genital Diseases, Male
Pathologic Processes
Prostatic Diseases
Urination Disorders
Urologic Diseases
Interventions listed in this trial
Dutasteride
More general drug interventions related to this trial
5-alpha Reductase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services